Healthcare utilization and costs in adults with stable and uncontrolled epilepsy

Epilepsy and Behavior

Volumn 31, Issue , 2014, Pages 356-362

  Cramer, Joyce A ^a   Wang, Zhixiao J ^b   Chang, Eunice ^c   Powers, Annette ^b   Copher, Ronda ^b   Cherepanov, Dasha ^c   Broder, Michael S ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EISAI INC   (United States)

^c PARTNERSHIP FOR HEALTH ANALYTIC RESEARCH   (United States)

Author keywords

Antiepileptic drugs; Cost analysis; Economics; Epilepsy; Medical care; Seizures

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; EMERGENCY WARD; EPILEPSY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH SERVICE; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; STABLE EPILEPSY; UNCONTROLLED EPILEPSY;

ANTIEPILEPTIC DRUGS; COST ANALYSIS; ECONOMICS; EPILEPSY; MEDICAL CARE; SEIZURES;

ADOLESCENT; ADULT; AGE FACTORS; ANTICONVULSANTS; COHORT STUDIES; COSTS AND COST ANALYSIS; DATABASES, FACTUAL; DELIVERY OF HEALTH CARE; EMERGENCY SERVICE, HOSPITAL; EPILEPSY; FEMALE; HOSPITALIZATION; HUMANS; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84892996187     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2013.09.046     Document Type: Article

References (33)

1. Lowenstein D.H. Seizures and epilepsy. Harrison's principles of internal medicine 2005, 2357-2372. McGraw-Hill, New York. D.L. Kasper, A.S. Fauci, D.L. Longo, E. Braunwald, S.L. Hauser, J.L. Jameson (Eds.).
2. Kobau R., Zahran H., Thurman D.J., Zack M.M., Henry T.R., Schachter S.C., et al. Epilepsy surveillance among adults - 19 states, behavioral risk factor surveillance system. MMWR Surveill Summ 2008, 57(6):1-20.
3. IOM (Institute of Medicine) Epilepsy across the spectrum: promoting health and understanding 2012, The National Academies Press, Washington, DC.
4. Murray M.I., Halpern M.T., Leppik I.E. Cost of refractory epilepsy in adults in the USA. Epilepsy Res 1996, 23:139-148.
5. Lee W.C., Arcona S., Thomas S.K., Wang Q., Hoffmann M.S., Pashos C.L. Effect of comorbidities on medical care use and cost among refractory patients with partial seizure disorder. Epilepsy Behav 2005, 7:123-126.
6. Lee W.C., Hoffmann M.S., Arcona S., D'Souza J., Wang Q., Pashos C.L. A cost comparison of alternative regimens for treatment-refractory partial seizure disorder: an econometric analysis. Clin Ther 2005, 27:1629-1638.
7. Hamer H.M., Spottke A., Aletsee C., Knake S., Reis J., Strzelczyk A., et al. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany. Epilepsia 2006, 47:2165-2172.
8. Yoon D., Frick K.D., Carr D.A., Austin J.K. Economic impact of epilepsy in the United States. Epilepsia 2009, 50:2186-2191.
9. Begley C.E., Famulari M., Annegers J.F., Lairson D.R., Reynolds T.F., Coan S., et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 2000, 41:342-351.
10. Strzelczyk A., Reese J.P., Dodel R., Hamer H.M. Cost of epilepsy: a systematic review. Pharmacoeconomics 2008, 26:463-476.
11. Ivanova J.I., Birnbaum H.G., Kidolezi Y., Qiu Y., Mallett D., Caleo S. Economic burden of epilepsy among the privately insured in the US. Pharmacoeconomics 2010, 28:675-685.
12. Manjunath R., Paradis P.E., Parisé H., Lafeuille M.H., Bowers B., Duh M.S., et al. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization. Neurology 2012, 79:1908-1916.
13. Davis K.L., Candrilli S.D., Edin H.M. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Epilepsia 2008, 49:446-454.
14. Ettinger A.B., Manjunath R., Candrilli S.D., Davis K.L. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav 2009, 14:324-329.
15. McDonagh M., Peterson K., Lee N., Thakurta S. Drug class review: antiepileptic drugs for indications other than epilepsy [Internet], [cited 2012 Nov 11]. Available from. http://derp.ohsu.edu/about/final-products.cfm.
16. O'Malley A.S., Pham H.H., Schrag D., Wu B., Bach P.B. Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics. Med Care 2007, 45(6):562-570.
17. Hwang W., Weller W., Ireys H., Anderson G. Out-of-pocket medical spending for care of chronic conditions. Health Aff 2001, 20:267-278.
18. HCUP Chronic Condition Indicator [Internet]. Rockville: Healthcare Cost and Utilization Project (HCUP); [updated 2011 Nov 10; cited 2012 Sep 5]. Agency for Healthcare Research and Quality. Available from: http://www.hcup-us.ahrq.gov/toolssoftware/chronic/chronic.jsp.
19. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
20. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-619.
21. Griffiths R.I., Schrammel P.N., Morris G.L., Wills S.H., Labiner D.M., Strauss M.J. Payer costs of patients diagnosed with epilepsy. Epilepsia 1990, 40:351-358.
22. Zachry W.M., Doan Q.D., Smith B.J., Clewell J.D., Griffith J.M. Direct medical costs for patients seeking emergency care for losses of epilepsy control in a U.S. managed care setting. Epilepsy Behav 2009, 16:268-273.
23. Ivanova J.I., Birnbaum H.G., Kidolezi Y., Qiu Y., Mallett D., Caleo S. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States. Epilepsia 2010, 51:838-844.
24. Kurth T., Lewis B.E., Alexander M.W. Health care resource utilization in patients with active epilepsy. Epilepsia 2010, 51:874-882.
25. Jennum P., Gyllenbord J., Kjellberg J. The social and economic consequences of epilepsy: a controlled national study. Epilepsia 2011, 52:949-956.
26. Boro A., Haut S. Medical comorbidities in the treatment of epilepsy. Epilepsy Behav 2003, 4:S2-S12.
27. Gaitatzis A., Carroll K., Majeed A., W Sander J. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004, 45:1613-1622.
28. Strine T.W., Kobau R., Chapman D.P., Thurman D.J., Price P., Balluz L.S. Psychological distress, comorbidities, and health behaviors among U.S. adults with seizures: results from the 2002 National Health Interview Survey. Epilepsia 2005, 46:1133-1139.
29. Seidenberg M., Pulsipher D.T., Hermann B. Association of epilepsy and comorbid conditions. Future Neurol 2009, 4:663-668.
30. Strzelczyk A., Nickolay T., Bauer S., Haag A., Knake S., Oertel W.H., et al. Evaluation of health-care utilization among adult patients with epilepsy in Germany. Epilepsy Behav 2012, 23:451-457.
31. Lu B., Elliott J.O. Beyond seizures and medications: normal activity limitations, social support, and mental health in epilepsy. Epilepsia 2012, 53:e25-e28.
32. Jetté N., Reid A.Y., Quan H., Hill M.D., Wiebe S. How accurate is ICD coding for epilepsy?. Epilepsia 2010, 51:62-69.
33. Tetto A., Manzoni P., Millul A., Beghi E., Garattini L., Tartara A., et al. Osservatorio Regionale per l'Epilessia (OREp). The costs of epilepsy in Italy: a prospective cost-of-illness study in referral patients with disease of different severity. Epilepsy Res 2002, 48:207-216.